Xueliang Du
- Epidemiology top 0.5%
- Physiology top 0.5%
- Molecular Biology top 5%
- Endocrinology, Diabetes and Metabolism top 1%
- Cardiology and Cardiovascular Medicine top 2%
- Co-authors
- Michael BrownleeAnders H. BergPhilipp E. SchererTerry P. CombsDiane EdelsteinTakeshi MatsumuraMichael W. RajalaLuciano Rossetti
- Topics
- Advanced Glycation End Products research (6 papers)Adipokines, Inflammation, and Metabolic Diseases (4 papers)Adipose Tissue and Metabolism (3 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Xueliang Du
22 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Epidemiology 2.7k
- Physiology 2.5k
- Molecular Biology 1.5k
- Endocrinology, Diabetes and Metabolism 1.1k
- Cardiology and Cardiovascular Medicine 897
Countries citing papers authored by Xueliang Du
This map shows the geographic impact of Xueliang Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueliang Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueliang Du more than expected).
Fields of papers citing papers by Xueliang Du
This network shows the impact of papers produced by Xueliang Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueliang Du. The network helps show where Xueliang Du may publish in the future.
Co-authorship network of co-authors of Xueliang Du
This figure shows the co-authorship network connecting the top 25 collaborators of Xueliang Du. A scholar is included among the top collaborators of Xueliang Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueliang Du. Xueliang Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 38 | |
| 2 | Abstract 20794: TNRC6 is a Master Regulator of microRNA Function in Myocardial Infarction | 1 |
| 3 | 91 | |
| 4 | 68 | |
| 5 | 141 | |
| 6 | 93 | |
| 7 | 6 | |
| 8 | 22 | |
| 9 | 181 | |
| 10 | C. elegans as model for the study of high glucose mediated lifespan reduction Running title: Glucose regulates lifespan in C. elegans | 1 |
| 11 | 271 | |
| 12 | 395 | |
| 13 | Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cellsbreakdown → | 629 |
| 14 | Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectinbreakdown → | 900 |
| 15 | Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathybreakdown → | 603 |
| 16 | 158 | |
| 17 | The adipocyte-secreted protein Acrp30 enhances hepatic insulin actionbreakdown → | 2075 |
| 18 | 11 | |
| 19 | 189 | |
| 20 | 72 |
About Xueliang Du
Xueliang Du is a scholar working on Aging, Clinical Biochemistry and Endocrine and Autonomic Systems, having authored 22 papers that have together received 6.0k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (6 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Adipose Tissue and Metabolism (3 papers). The work is most often cited by research in Endocrine and Autonomic Systems (865 citations), Clinical Biochemistry (865 citations) and Physiology (2.5k citations). Xueliang Du has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Michael Brownlee, Anders H. Berg, Philipp E. Scherer, Terry P. Combs, Diane Edelstein, Takeshi Matsumura, Michael W. Rajala, Michael Brownlee, Luciano Rossetti and Csaba Szabó. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.